Expert Review of Pharmacoeconomics & Outcomes Research

Article	Citations
Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy	166
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications	47
Distinguishing features in the assessment of mHealth apps	37
Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic	36
Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses	32
Organizational measures aiming to combat COVID-19 in the Russian Federation: the first experience	32
Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review	28
Tools to assess the quality of life in patients with Parkinson’s disease: a systematic review	28
First-line atezolizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer: a cost-effectiveness analysis from China	26
Health-related quality of life in patients with chronic kidney disease	25
Will the Markov model and partitioned survival model lead to different results? A review of recent economic evidence of cancer treatments	23
Evaluation instruments for executive functions in children and adolescents: a systematic review	19
Outcome measures for physical fatigue in individuals with multiple sclerosis: a systematic review	17
Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease	16
Valuing health outcomes: developing better defaults based on health opportunity costs	16
Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia	15
Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing	14
A comparison of measurement properties between UK SF-6D and English EQ-5D-5L and Thai EQ-5D-5L value sets in general Thai population	14
Cost-effectiveness of adding durvalumab to first-line chemotherapy for extensive-stage small-cell lung cancer in China	14
Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study	14
Gap analysis in manufacturing, innovation and marketing of medical devices in the Asia-Pacific region	13
Challenges in demonstrating the value of disease-modifying therapies for Alzheimer’s disease	13
Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis	12
Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in Singapore	12
Estimating the economic consequences of substance use and substance use disorders	11

The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review	11
Economic burden associated with stroke in India: insights from national sample survey 2017-18	10
The pharmacoeconomic impact of follitropin alpha biosimilars in IVF therapy in Europe: a report of the literature	10
Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review	10
Artificial intelligence in outcomes research: a systematic scoping review	10
A review of quality-of-life in elderly osteoarthritis	10
Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia	10
Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder	9
Can we achieve affordable cancer medicine prices? Developing a pathway for change	9
Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspe	9
How do biosimilars sustain value, affordability, and access to oncology care?	9
Cannabis use among Canadian adults with cancer (2007–2016): results from a national survey	8
Economic evaluation of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer: systematic review and quality assessment	8
Cost-effectiveness of osimertinib versus standard EGFR-TKI as first-line treatment for locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer in Australia	8
Not cost-effective at zero price: valuing and paying for combination therapies in cancer	8
Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system	8
Cost of illness in multiple sclerosis by disease characteristics – A review of reviews	8
Cost-effectiveness analysis of donafenib versus lenvatinib for first-line treatment of unresectable or metastatic hepatocellular carcinoma	8
Economic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population	8
Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience	8
An update on the economic burden of type 2 diabetes mellitus in China	8
Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia	8
Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications	8
Trends in the pricing and reimbursement of new anticancer drugs in South Korea: an analysis of listed anticancer drugs during the past three years	7
Exploring the consistency of the SF-6Dv2 in a breast cancer population	7
Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer	7
In-hospital economic burden of anastomotic leakage after colorectal anastomosis surgery: a real-world cost analysis in Italy	7
Understanding long-listed pharmaceutical products without competition in South Korea: policy implications in managing generic entrants and pharmaceutical expenditures	7
Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan	7
Evidence of long-term real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic	7
Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I study	7
Cost-effectiveness of olaparib maintenance therapy when used with and without restriction by BRCA1/2 mutation status for platinum-sensitive relapsed ovarian cancer	7
Pembrolizumab plus lenvatinib or axitinib compared to nivolumab plus ipilimumab or cabozantinib in advanced renal cell carcinoma: a number needed to treat analysis	6
Cost-effectiveness analyses of targeted therapy and immunotherapy for advanced non-small cell lung cancer in the United States: a systematic review	6
Cost of patients with hemophilia A treated with standard half-life or extended half-life FVIII in Spain	6
Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Gr	6
Disease burden on health care by pain severity and usual analgesic treatment in patients with symptomatic osteoarthritis: a Spanish nationwide health survey	6
All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain	6
The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology	6
The economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention	6
Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia	6
Cost-effectiveness analyses comparing cemented, cementless, hybrid and reverse hybrid fixation in total hip arthroplasty: a systematic overview and critical appraisal of the current evidence	6
Prevalence and direct costs of potentially inappropriate prescriptions in France: a population-based study	5
Pharmacoeconomics of obesity in China: a scoping review	5
Healthcare resource utilization in patients with newly diagnosed atrial fibrillation in the United States	5
The costs of treatment resistant depression: evidence from a survey among Italian patients	5
Cost-effectiveness analysis of tofacitinib compared with adalimumab and etanercept in the treatment of severe active rheumatoid arthritis; Iranian experience	5
Direct medical costs of breast cancer in Jordan: cost drivers and predictors	5
How can societal culture and values influence health and rehabilitation outcomes?	5
Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews	5

Assessing the pricing and benefits of oncology products: an update	5
Short-term societal economic burden of first-incident type 2 diabetes-related complications – a nationwide cohort study	5
The value of communicating with patients in their first language	5
Pharmaco-utilization of biologic drugs in patients affected by psoriasis, psoriatic arthritis and ankylosing spondylitis in an Italian real-world setting	5
Incremental cost-effectiveness analysis of tyrosine kinase inhibitors in advanced non-small cell lung cancer with mutations of the epidermal growth factor receptor in Colombia	5
Cost-effectiveness of aripiprazole orally disintegrating tablets in the treatment of schizophrenia in China	5
Assessment of the properties of the EQ-5D-5L in patients with type 2 diabetes mellitus: a systematic review and meta-analysis	5
A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury	5
Durvalumab consolidation therapy in patients with stage III non-small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis	5
Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies	5
Cost-utility analysis of ceftazidime-avibactam versus colistin-meropenem in the treatment of infections due to Carbapenem-resistant Klebsiella pneumoniae in Colombia	5
Cost-effectiveness analysis of apixaban compared to other direct oral anticoagulants for prevention of stroke in Austrian atrial fibrillation patients	5
A systematic review and meta-regression of studies eliciting willingness-to-pay per quality-adjusted life year in the general population	5
Budget impact analysis of subcutaneous trastuzumab compared to intravenous trastuzumab in Saudi HER2-positive breast cancer patients	5
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis	5
Burden of illness the first year after diagnosed bladder dysfunction among people with spinal cord injury or multiple sclerosis – a Danish register study	5
Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2– metastatic breast cancer in the United States	5
The Economic and societal burden of multiple sclerosis on lebanese society: a cost-of-illness and quality of life study protocol	5
Bringing the patient’s perspectives forward in drug development and health-care evaluation	4
A pre-vaccine analysis using the Health Belief Model to explain parents’ willingness to vaccinate (WTV) their children in the United States: implications for vaccination programs	4
Preference of young adults for COVID-19 vaccination in the United Kingdom: a discrete choice experiment	4
Economic evaluation of ivabradine in treatment of patients with heart failure: a systematic review	4
Cost-related nonadherence for prescription medications: a cross-sectional study in Jordan	4
Burden of disease and costs of infections associated with cardiac implantable electronic devices	4
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain	4
A review of caregiver costs included in cost-of-illness studies	4
Characterization of health-related quality of life based on the EQ-5D-5L questionnaire in head-and-neck cancer patients undergoing modern radiotherapy	4
A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.	4
Budget impact analysis of medicines: estimated values versus real-world evidence and the implications	4
Is it a chimera? A systematic review of the economic evaluations of CAR-T cell therapy - an update	4
The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States	4
Systematic reviews of machine learning in healthcare: a literature review	4
Economic evaluation of toripalimab plus chemotherapy compared with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma in China	4
Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain	4
Letter to the editor on ‘cognitive behavior therapy for health anxiety: systematic review and meta-analysis of clinical efficacy and health economic outcomes’	4
The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey	4
Early technology assessment of using whole genome sequencing in personalized oncology	4
Value elements and methods of value-based pricing for drugs in Japan: a systematic review	4
Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china	4
Cost-utility analysis of stereotactic body radiotherapy plus cetuximab in previously irradiated recurrent squamous cell carcinoma of the head and neck	4
Assessment of women’s treatment preferences for vasomotor symptoms due to menopause	4
Identification of risk factors of 30-day readmission and 180-day in-hospital mortality, and its corresponding relative importance in patients with Ischemic heart disease: a machine learning approach	4
Evaluation of quality of pharmacoeconomic studies involved in traditional Chinese medicine in China	4
How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015–2021	3
Cost-benefit analysis of hepatic resection, radiofrequency ablation and liver transplantation in small hepatocellular carcinoma	3
Cost-effectiveness analysis of the first‐line EGFR‐TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer	3
Can artificial intelligence separate the wheat from the chaff in systematic reviews of health economic articles?	3
Patient associations and clinical oncology research: how much does a patient’s voice really matter?	3
Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis	3
Pharmacist-directed care to optimize medication use: a healthcare imperative in the United States	3
Combining health technology assessment and health technology management to deliver cost-effective prescribing and cost containment – the Irish experience	3
Cost-effectiveness of acalabrutinib regimens in treatment-naïve chronic lymphocytic leukemia in the United States	3
Burden of depression among Canadian adults with cancer; results from a national survey	3
The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices	3
The affordability of adding a direct-acting oral anticoagulant to the national list of essential medicine for patients with non-valvular atrial fibrillation in Thailand: a budget impact analysis	3
Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as combination therapy with metformin in the treatment of type 2 diabetes mellitus without established cardiovascular disease in Colomb	3
Incorporating health inequality impact into economic evaluation in low- and middle-income countries: a systematic review	3
Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal	3
Cost-effectiveness of pharmacist-led care versus usual care in type 2 diabetic Jordanians: a Markov modeling of cardiovascular diseases prevention	3
Summary of the 2020 AHRQ research meeting on ‘advancing methods of implementing and evaluating patient experience improvement using consumer assessment of healthcare providers and systems (CAHPS®) sur	3
Canadian French translation and linguistic validation of the health-related quality of life utility measure for pre-school children	3
Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil	3
A landscape analysis and discussion of value of gene therapies for sickle cell disease	3
Tenecteplase in managing acute ischemic stroke: a long-term cost–utility analysis in Iran	3
Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review	3
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain	3
Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model	3
Cost-effectiveness analysis of polycystic ovary syndrome management and the risk of gestational diabetes in pregnant women: a decision-tree model	3
Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease	3
Assessing the impact of kidney cancer-related premature mortality and productivity loss in Greece and Portugal	3
Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events	3
Design and testing of a health economic Markov model for treatment of anorexia nervosa	3
A systematic review of cost-effectiveness analyses across the acute kidney injury landscape	3
Economic evaluation of reproductive carrier screening for recessive genetic conditions: a systematic review	3
Tackling reimbursement challenges to fair access to medicines – introduction to the topic	3
A comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer	3
Predicting key drivers for health care expenditure growth in the Middle East region: a Grossman-PLS modeling approach	3
Patient preferences for elagolix and leuprolide for treating endometriosis-related pain in the United States	3
Budget impact of introducing subcutaneous vedolizumab as a maintenance therapy in biologic-naïve and biologic-experienced patients with ulcerative colitis in France	3
Cost-effectiveness of camrelizumab plus chemotherapy versus chemotherapy alone as first-line therapy in advanced or metastatic esophageal squamous cell carcinoma	3

Multicriteria decision analysis in health care decision in oncology: a systematic review	3
Moving beyond the stage: how characteristics at diagnosis dictate treatment and treatment-related quality of life year losses for women with early stage invasive breast cancer	3
Economic analysis of cerliponase alfa for treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2)	2
Exploring the status and views of managed entry agreements in Saudi Arabia: mixed-methods approach	2
Assessment of the quality and trend of reporting of health economic evaluation research in India	2
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain	2
Access and pricing of medicines for patients with rare diseases in the European Union: an industry perspective	2
Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review	2
Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?	2
Estimating cost-effectiveness of screening for colorectal cancer in Vietnam	2
Economic evaluation of interventions to improve medication adherence among patients with chronic diseases: an overview of systematic reviews	2
Conducting economic evaluation based on basket clinical trial in the area of precision medicine	2
Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study	2
Cost-effectiveness of childhood influenza vaccination in Europe: results from a systematic review	2
Medicaid best price reforms to enable innovative payment models for cell and gene therapies	2
The societal costs of multiple sclerosis in Lebanon: a cross-sectional study	2
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant	2
Burden of illness among intermittent catheter users with non-neurogenic urinary retention in Denmark	2
Burden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE study	2
Story completion (SC) – an epistemological approach to the interpretation of patient-reported outcomes?	2
Assessment of Quality of Life 8-Dimension (AQoL-8D): translation, validation, and application in two Dutch trials in patients with epilepsy and schizophrenia	2
The impact of universal health coverage and COVID-19 pandemic on out-of-pocket expenses in Thailand: an analysis of household survey from 1994 to 2021	2
Value assessment of new interventions for Alzheimer’s disease dementia in Japan based on literature review and group interview	2
In our war against the opioid epidemic, could ‘weed’ be a winner?	2
Health economic evaluation of different treatment strategies for peripheral entrapment mononeuropathies: a systematic review	2
Measuring valued output in primary care: challenges and reconciliation	2
Estimation of the economic burden of atrial fibrillation-related stroke in Greece	2
Budgetary impact analysis of alteplase - recombinant tissue plasminogen activator (rtPA) - as a thrombolytic treatment for acute ischemic stroke in Colombia	2
Analysis of patients’ access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece	2
Comparing multi-attribute utility instruments: CP-6D, a Cerebral palsy specific instrument, vs AQoL-4D	2
Hospital incidence, mortality and costs of Alzheimer’s disease in Spain: a retrospective multicenter study	2
Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare	2
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer	2
Social and economic burden of breast cancer in the North East region of Bulgaria	2
A systematic review of pharmacoeconomic evaluations on oral diarylquinoline-based treatment for drug-resistant tuberculosis: from high to low burden countries	2
Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care	2
Cost-effectiveness of daratumumab in combination with lenalidomide and dexamethasone for relapsed and/or refractory multiple myeloma	2
Performance-based risk-sharing agreements in renal care: current experience and future prospects	2
Evaluating high-cost technologies – no need to throw the baby out with the bathwater	2
Health-related quality of life in women with autoimmune thyroid disease during pregnancy and postpartum: systematic review including 321,850 pregnancies	2
Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs	2
A systematic review of economic evaluations of vaccines in Middle East and North Africa countries: is existing evidence good enough to support policy decision-making?	2
Review of economic modeling evidence from NICE appraisals of rare disease treatments for spinal muscular atrophy	2
Assessing smoking cessation services and pharmacotherapy in Namibia: findings and implications for future policy initiatives	2
Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review	2
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada	2
Prescription analysis and cost of antidepressant drugs in major depressive disorder outpatients at the tertiary care hospital of Pakistan: a prospective approach	2
Hyperbaric oxygen therapy as an adjunct to the standard wound care for the treatment of diabetic foot ulcers in Indian patients: a cost utility analysis	2
Cost-effectiveness of nivolumab in advanced melanoma: a drug review	2
Association of congestive heart failure with hospital outcomes among renal cancer patients in the United States: analysis of nationwide inpatient sample	2
Early economic evaluation of an intervention to improve uptake of the NHS England Diabetes Prevention Programme	2
Pattern of drug use in patients with psoriatic arthritis in Italy: study in a real-world setting	2
Hospital care of endometriosis in Spain: a retrospective multicenter analysis of patient characteristics and costs	2
Incorporating patients’ preferences in the value assessment of disease-modifying therapies for multiple sclerosis: a narrative review	2
Mapping the FACT-G to EQ-5D-3L utility index in cancer with the Chinese values set	2
Burden of disease of chronic pain in Colombia	2
Disease and economic burden of surgery in desmoid tumors: a review	2
Trastuzumab biosimilar HLX02 versus reference trastuzumab in patients with recurrent or metastatic HER2-positive breast cancer: a model-based economic evaluation for China	2
The challenge of value-based pricing in combination therapy: the case of trastuzumab and pertuzumab in HER2+ metastatic breast cancer	2
Risk prediction algorithms in guiding antiviral therapy initiation among patients with chronic hepatitis B in Thailand: an economic evaluation and budget impact analysis	1
Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological ana	1
The budget impact of introducing the OMNI® surgical system to a United States health plan for managing mild-to-moderate primary open-angle glaucoma	1
Psychometric properties of the Polish version of SF-12v2 in the general population survey	1
A visual approach to the economic evaluation of vaccines: opening the health economic black box	1
Economic benefits of global Collaborative Health technology	1
Direct medical and indirect absenteeism costs among working adult ADHD patients in the United States	1
Clinical and economic outcomes associated with intravenous albumin fluid use in the intensive care unit: a retrospective cohort study	1
Economic value of knowing BRCA status: BRCA testing for prostate cancer prevention and optimal treatment	1
Cost-effectiveness analysis of atezolizumab plus chemotherapy as first-line treatment for patients with advanced nonsquamous non-small-cell lung cancer in China	1
Cost considerations of dermatological care in Jordan: a cross-sectional study	1
An early health technology assessment of 3D anatomic models in pediatric congenital heart surgery: potential cost-effectiveness and decision uncertainty	1
Atopic dermatitis in specialized centers in Spain: a retrospective analysis of incidence and costs (2000-2017)	1
Cost-effectiveness analysis of nivolumab-chemotherapy as first-line therapy for locally advanced/metastatic gastric cancer: a United States payer perspective	1
Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand	1
Value-based health care in Western countries: a scoping review on the implementation of patient-reported-outcomes sets for hospital-based interventions	1
What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?	1
Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database	1
Cost-effectiveness and drug wastage of immunotherapeutic agents for hematologic malignancies: a systematic review	1
Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review	1
Effects, trends, costs associated with readmission in early-aged patients with suicidal ideation	1
Economic evaluation of plerixafor addition in the mobilization and leukapheresis of hematopoietic stem cells for autologous transplantation: a systematic review	1
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?	1
Measuring health-related quality of life in patients treated for substance dependence: differences among instruments and methods of eliciting preferences	1
Use of machine learning to predict bladder cancer survival outcomes: a systematic literature review	1
Seeing the whole elephant: integrated advanced data analytics in support of RWE for the development and use of innovative pharmaceuticals	1
The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach	1
The cost-effectiveness of using rapid diagnostic tests for the diagnosis of typhoid fever in patients with suspected typhoid fever: a systematic review	1
Value-based performance arrangements for chronic conditions: an economic simulation of Medicaid Drug Rebate Program reforms	1
Overview and quality assessment of health economic evaluations for homeopathic therapy: an updated systematic review	1
A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis	1
Evaluating the correlations of cost and utility parameters from summary statistics for probabilistic analysis in economic evaluations	1
Effects of utilization management on health outcomes: evidence from urinary tract infections and community-acquired pneumonia	1
Analysis of the prevalence of ankylosing spondylitis and treatment patterns and drug utilization among affected patients: an Italian real-world study	1
Health equity and the usage of atypical antipsychotics within the Brazilian national health system: findings and implications	1
Digital measures in epilepsy in low-resourced environments	1